Sym-021
Sym-021 is a human monoclonal antibody (mAb) targeting PDCD1/PD-1/CD279. Sym-021 blocks the binding of PD-L1 and PD-L2 ligands, inducing the secretion of interferon IFN-γ and IL-2 and the proliferation of T cells. Sym-021 has anti-tumor activity in PDX mouse models[1].
Product Specifications
UNSPSC
12352203
Target
PD-1/PD-L1
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Sym-021]
References & Citations
[1]Gjetting T, et al. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform. MAbs. 2019 May/Jun;11 (4) :666-680.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A2160-5mg*20 20x 5mg
Anti-rat Kappa Immunoglobulin Light Chain-InVivo
Sign In for Pricing
View Details P501920 100 µg
CD300f/CD300LF Protein (N-His, Mus musculus (Mouse) )
Sign In for Pricing
View Details 
155170-01 10 µg
Inhibitory Subunit Of NF Kappa B Alpha (IkBa) Recombinant, Human
Sign In for Pricing
View Details